Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blank

Showing results (81-90 of 727) with videos related to

Pageof 73
Sort By:
The Journal of Trauma|May 1, 1996
Left anterior descending artery occlusion after blunt chest traumaA Salmi, M Blank, C Slomski
Current Opinion in Biotechnology|December 11, 2012
From measurement to implementation of metabolic fluxesLars M Blank, Birgitta E Ebert
Scandinavian Journal of Rheumatology. Supplement|October 6, 1998
Immunomodulation of experimental antiphospholipid syndromeY Sherer, M Blank, Y Shoenfeld
Annals of the Rheumatic Diseases|January 1, 1997
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulationY Shoenfeld, I Krause, M Blank
Journal of Health Care for the Poor and Underserved|January 1, 1995
De facto mental health services in the rural southJ Fox, E Merwin, M Blank
Current Opinion in Biotechnology|October 23, 2012
Phosphorus biotechnologyAndrew N Shilton, Lars M Blank
Clinical and Experimental Rheumatology|May 17, 2000
The induction of experimental vascular diseases by immunization with pathogenic autoantibodiesI Krause, M Blank, Y Shoenfeld
Clinical and Experimental Rheumatology|August 19, 2000
The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them?Y Shoenfeld, M Blank, I Krause
The Israel Medical Association Journal : IMAJ|May 24, 2001
New treatment avenues: oral tolerance--mechanisms and applicability to human diseasesI Krause, M Blank, Y Shoenfeld
In Vivo (Athens, Greece)|July 1, 1995
Circasemiseptan (about-half-weekly) and/or circaseptan (about-weekly) pattern in human mitotic activity?M Blank, G Cornélissen, F Halberg
Pageof 73

Showing results (81-90 of 727) with videos related to

Sort By:
Pageof 73
The Journal of Trauma|May 1, 1996
Left anterior descending artery occlusion after blunt chest traumaA Salmi, M Blank, C Slomski
Current Opinion in Biotechnology|December 11, 2012
From measurement to implementation of metabolic fluxesLars M Blank, Birgitta E Ebert
Scandinavian Journal of Rheumatology. Supplement|October 6, 1998
Immunomodulation of experimental antiphospholipid syndromeY Sherer, M Blank, Y Shoenfeld
Annals of the Rheumatic Diseases|January 1, 1997
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulationY Shoenfeld, I Krause, M Blank
Journal of Health Care for the Poor and Underserved|January 1, 1995
De facto mental health services in the rural southJ Fox, E Merwin, M Blank
Current Opinion in Biotechnology|October 23, 2012
Phosphorus biotechnologyAndrew N Shilton, Lars M Blank
Clinical and Experimental Rheumatology|May 17, 2000
The induction of experimental vascular diseases by immunization with pathogenic autoantibodiesI Krause, M Blank, Y Shoenfeld
Clinical and Experimental Rheumatology|August 19, 2000
The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them?Y Shoenfeld, M Blank, I Krause
The Israel Medical Association Journal : IMAJ|May 24, 2001
New treatment avenues: oral tolerance--mechanisms and applicability to human diseasesI Krause, M Blank, Y Shoenfeld
In Vivo (Athens, Greece)|July 1, 1995
Circasemiseptan (about-half-weekly) and/or circaseptan (about-weekly) pattern in human mitotic activity?M Blank, G Cornélissen, F Halberg
Pageof 73